glp 1 compounds glp-1 semaglutide compound FDA Warns on Certain Forms of Compounded Semaglutide There's a lot of controversy
Description
doi: 10.2337/diabetes.53.5.1326
Notably, a significant proportion (49.6%) of GLP-1 RAs users had already been on these medications prior to the index hospital discharge

13 A meta-analysis of RCTs among patients with type 2 diabetes and myocardial infarction suggested that GLP-1RA may be associated with a lower risk of atrial arrhythmia compared with placebo

But there's a catch (isn't there always?)

Patients were considered to be on treatment for the period during which prescriptions were refilled before the estimated end date of the most recent prescription, including a 90-day grace period, i.e